IMMUNE INSIGHTS
Imperial’s human challenge study helps explain why some people don’t get COVID
New analysis based on Imperial’s COVID-19 human challenge study has helped to uncover how some people avoid getting sick.
Stories tagged with 'Coronavirus'
City climate action
Health risk from global warming predictor of city climate action during COVID-19
City officials were more likely to maintain climate action during the pandemic in places with more climate-related health issues affecting residents.
Blood markers
Long COVID leaves telltale traces in the blood
People with long COVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies.
5
Feature
Bench to bedside
Eight things we learned about commercialising medical research at AYCI 2024
We learnt why you should channel Mary Somerville, how timing can make or break a startup, and other lessons from experts at All You Can Innovate 2024.
Virology and Vaccines
Imperial launches new online courses on virology and vaccinology
A new online Coursera series will explore how viruses infect us, how vaccines protect us and the latest cutting-edge infectious disease research.
Infection studies
Global human challenge consortium to push for next generation of vaccines
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.
COVID-19 cognition
COVID-19 may have small but lasting effects on cognition and memory
COVID-19 may have an impact on people’s cognitive and memory abilities that lasts a year or more after infection.
T CELL RESPONSES
T cells may provide more durable protection against Omicron than antibodies
New review suggests T cells are more robust against ‘Omicron breakthroughs’ than antibodies, offering fresh insights for COVID-19 vaccine development.
Pandemic legacy
Soaring childhood obesity from pandemic could cost UK billions
A major spike in child obesity levels during the pandemic could cost the UK over £8 billion, according to a study involving Imperial researchers.
COVID antibody boost
Immunosuppressing medicine can be interrupted to boost COVID-19 vaccine response
Interrupting treatment of immunosuppressing medicines for two weeks can significantly improve antibody immunity provided by COVID-19 booster vaccines.
